New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
Drug that blocks blood vessel growth could treat rare sarcomas

Drug that blocks blood vessel growth could treat rare sarcomas

by Institute of Cancer ResearchImage: Alveolar Soft Part Sarcoma. Credit: Michael Bonert.Licence: CC BY-SA 3.0An experimental targeted drug could treat a rare type of cancer usually affecti
Oncology April 01,2024
Drug that blocks blood vessel growth could treat rare sarcomas

Drug that blocks blood vessel growth could treat rare sarcomas

by Institute of Cancer ResearchImage: Alveolar Soft Part Sarcoma. Credit: Michael Bonert.Licence: CC BY-SA 3.0An experimental targeted drug could treat a rare type of cancer usually affecti
Oncology April 01,2024
Automated bone scan index prognostic for prostate cancer

Automated bone scan index prognostic for prostate cancer

(HealthDay)—The automated Bone Scan Index (aBSI) is an independent prognostic imaging biomarker of overall survival (OS) in metastatic castration-resistant prostate cancer (mCRPC), according to a stud
Oncology April 01,2024
Automated bone scan index prognostic for prostate cancer

Automated bone scan index prognostic for prostate cancer

(HealthDay)—The automated Bone Scan Index (aBSI) is an independent prognostic imaging biomarker of overall survival (OS) in metastatic castration-resistant prostate cancer (mCRPC), according to a stud
Oncology April 01,2024
Blocking a survival mechanism could tackle melanoma treatment resistance

Blocking a survival mechanism could tackle melanoma treatment resistance

by Cancer Research UKAdding an inhibitor compound to cancer cells for analysis of how it affects cell signalling, growth and survival. Credit: the Babraham InstituteThe effectiveness of current t
Oncology April 01,2024
Blocking a survival mechanism could tackle melanoma treatment resistance

Blocking a survival mechanism could tackle melanoma treatment resistance

by Cancer Research UKAdding an inhibitor compound to cancer cells for analysis of how it affects cell signalling, growth and survival. Credit: the Babraham InstituteThe effectiveness of current t
Oncology April 01,2024
Two types of HPV linked to cervical cancer have declined since the advent of the HPV vaccine

Two types of HPV linked to cervical cancer have declined since the advent of the HPV vaccine

by American Association for Cancer ResearchElectron micrograph of a negatively stained human papilloma virus (HPV) which occurs in human warts. Credit: public domainAn analysis of cervical precan
Oncology April 01,2024
Two types of HPV linked to cervical cancer have declined since the advent of the HPV vaccine

Two types of HPV linked to cervical cancer have declined since the advent of the HPV vaccine

by American Association for Cancer ResearchElectron micrograph of a negatively stained human papilloma virus (HPV) which occurs in human warts. Credit: public domainAn analysis of cervical precan
Oncology April 01,2024
Self-testing cervical cancer screening could save Māori women's lives

Self-testing cervical cancer screening could save Māori women's lives

by Victoria University of WellingtonElectron micrograph of a negatively stained human papilloma virus (HPV) which occurs in human warts. Credit: public domainCervical cancer is the second leading
Oncology April 01,2024
Self-testing cervical cancer screening could save Māori women's lives

Self-testing cervical cancer screening could save Māori women's lives

by Victoria University of WellingtonElectron micrograph of a negatively stained human papilloma virus (HPV) which occurs in human warts. Credit: public domainCervical cancer is the second leading
Oncology April 01,2024
Autism-associated gene appears to alter brain cell identity in the hippocampus

Autism-associated gene appears to alter brain cell identity in the hippocampus

by UT Southwestern Medical CenterThis image, obtained from a mouse brain using a brightfield microscope, shows the richly diverse cells of the hippocampus pseudocolored with different hues. Maria
Oncology April 01,2024
Autism-associated gene appears to alter brain cell identity in the hippocampus

Autism-associated gene appears to alter brain cell identity in the hippocampus

by UT Southwestern Medical CenterThis image, obtained from a mouse brain using a brightfield microscope, shows the richly diverse cells of the hippocampus pseudocolored with different hues. Maria
Oncology April 01,2024
Blocking inflammatory pathway key to preventing brain metastasis from melanoma

Blocking inflammatory pathway key to preventing brain metastasis from melanoma

by Tel Aviv UniversityMelanoma. Credit: Wikimedia Commons/National Cancer InstituteBrain metastases are among the deadliest tumor metastases, with a median survival period of less than one year,
Oncology April 01,2024
Blocking inflammatory pathway key to preventing brain metastasis from melanoma

Blocking inflammatory pathway key to preventing brain metastasis from melanoma

by Tel Aviv UniversityMelanoma. Credit: Wikimedia Commons/National Cancer InstituteBrain metastases are among the deadliest tumor metastases, with a median survival period of less than one year,
Oncology April 01,2024
Overall cancer mortality continues to decline, prostate cancer mortality has stabilized

Overall cancer mortality continues to decline, prostate cancer mortality has stabilized

by National Cancer InstituteCancer cell during cell division. Credit: National Institutes of HealthThe latest Annual Report to the Nation on the Status of Cancer finds that overall cancer death r
Oncology April 01,2024
Overall cancer mortality continues to decline, prostate cancer mortality has stabilized

Overall cancer mortality continues to decline, prostate cancer mortality has stabilized

by National Cancer InstituteCancer cell during cell division. Credit: National Institutes of HealthThe latest Annual Report to the Nation on the Status of Cancer finds that overall cancer death r
Oncology April 01,2024
Second opinions from comprehensive cancer centers changed treatment plans for African-American patients

Second opinions from comprehensive cancer centers changed treatment plans for African-American patients

by American Association for Cancer ResearchCancer cell during cell division. Credit: National Institutes of HealthAfrican American breast cancer patients who received second opinions from an NCI-
Oncology April 01,2024
Second opinions from comprehensive cancer centers changed treatment plans for African-American patients

Second opinions from comprehensive cancer centers changed treatment plans for African-American patients

by American Association for Cancer ResearchCancer cell during cell division. Credit: National Institutes of HealthAfrican American breast cancer patients who received second opinions from an NCI-
Oncology April 01,2024
Blocking key pathways is a way to defeat cancer stem cells

Blocking key pathways is a way to defeat cancer stem cells

by RIKENCancer cell during cell division. Credit: National Institutes of HealthScientists from the RIKEN Center for Integrative Medical Sciences in Japan and international collaborators have foun
Oncology April 01,2024
Blocking key pathways is a way to defeat cancer stem cells

Blocking key pathways is a way to defeat cancer stem cells

by RIKENCancer cell during cell division. Credit: National Institutes of HealthScientists from the RIKEN Center for Integrative Medical Sciences in Japan and international collaborators have foun
Oncology April 01,2024
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com